Stay updated on DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.

Latest updates to the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1). The 'Back to Top' link was removed.SummaryDifference0.3%
- Check12 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as new medical topics related to cancer and chemotherapy agents. Notably, previous entries related to certain genetic diseases and specific cancer topics have been removed.SummaryDifference8%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.